Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 4Non-Muscle Invasive Bladder Neoplasms 2Neoplasm Metastasis 2Recurrence Hepatocellular Carcinoma 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Anus Neoplasms 1

Interventions

Mitomycin 1Ethiodized Oil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Recurrence Hepatocellular Carcinoma × Mitomycin × Clear all
NCT02638857 2016-01-01

Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma

Second Military Medical University

Phase 1/2 Unknown
60 enrolled
Gastrointestinal

Recurrence Hepatocellular Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡